Abstract
Diabetic kidney disease (DKD) is the leading cause of end stage kidney disease in the world. Currently, treatments are mainly based on blood glucose and blood pressure control, but clinical studies suggest that they have a mild or neutral positive effect on the progression of DKD once renal dysfunction has already been established. Hyperglycemia, one of the main supporting elements in the…